SECsense Logo

Aptose Biosciences Inc. 8-K Report: Key Updates for Investors

$APTO
Form 8-K
Filed on: 2025-02-18
Source
Aptose Biosciences Inc. 8-K Report: Key Updates for Investors

Based on the provided section of the financial report, here are the key details and insights extracted:

  1. Entity Information:
  • Company Name: Aptose Biosciences Inc.
  • CIK Number: 0000882361
  • Address: 66 Wellington Street West, Suite 5300 TD Bank Tower, Box 48, Toronto, ON M5K 1E6
  • Phone Number: 310-849-8060
  • SEC File Number: 001-32001
  • Tax ID: 98-1136802
  1. Filing Information:
  • Form Type: 8-K (Current Report)
  • Filing Date: February 18, 2025
  1. Financial Metrics:
  • Unit of Measurement:
    • USD (United States Dollar)
    • Shares
    • USD per Share
  • Common Shares: The report mentions "Common Shares, no par value", indicating that the company has issued common stock without a specified par value.
  1. Stock Information:
  • Ticker Symbol: APTO
  • Exchange: NASDAQ
  1. Context:
  • The filing appears to be a current report (Form 8-K), which is typically used to announce major events that shareholders should be aware of, suggesting that important information was disclosed on the filing date.

Insights:

  • The report is likely related to corporate actions or developments that could affect shareholder value or company operations, given that it is an 8-K filing.
  • Investors and stakeholders should pay attention to this filing for updates on the company's performance or significant events that may impact its stock price or business strategy.
  • The lack of a par value on common shares can provide flexibility in financial structuring for the company.

Overall, this section outlines essential identifiers for the company and its financial reporting, emphasizing the significance of the 8-K filing for stakeholders.